Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Explore withdrawal approaches for portfolios with SP 500 and Total Stock Market funds to sustain income and minimize risk.
28,406 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Many assume Social Security means retirement income with no job. The reality is more nuanced: you can work while coll...
A focused AI tilt ETF called CHAT can outperform broad tech in some periods, but XLK’s lower fees often matter more f...
A small stake in a leading solar company sparked big learning for investors. This million solar lands move shows how ...
Turning Point Brands stock took a sharp drop this week as investors weighed a disappointing quarter and cautious guid...
AutoZone recently missed Wall Street estimates, sending shares lower before stabilizing. This guide breaks down what ...
Netflix trades below $78 as investors weigh ad-supported growth and margin targets. Analysts dispute whether the stoc...
ALPS Equal Sector Weight ETF (EQL) is delivering solid returns as SPY pulls back, but a crowded market still favors c...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
Stock splits often signal strong momentum. Here are three stock-split stocks before they soar, with practical analysi...
Investors are weighing where will spacex stock go over the next 12 months. This guide breaks down the drivers, scenar...
Two popular bond funds target different corners of the fixed-income market. This guide breaks down how Vanguard Long-...